Publisher： Bentham Science Publishers
E-ISSN： 1873-4294|14|16|1890-1898
ISSN： 1568-0266
Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.16, 2014-08, pp. : 1890-1898
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
De novo drug design methods such as receptor or protein based pharmacophore modeling present a unique opportunity to generate novel ligands by employing the potential binding sites even when no explicit ligand information is known for a particular target. Recent developments in molecular modeling programs have enhanced the ability of early programs such as LUDI or Pocket that not only identify the key interactions or hot spots at the suspected binding site, but also and convert these hot spots into three-dimensional search queries and virtual screening of the property filtered synthetic libraries. Together with molecular docking studies and consensus scoring schemes they would enrich the lead identification processes. In this review, we discuss the ligand and receptor based de novo drug design approaches with selected examples.
Related content
Access to resources
Recommend
Pharmacophore-Based Virtual Screening
Current Medicinal Chemistry, Vol. 15, Iss. 10, 2008-04 ,pp. :
Computational Approaches for Fragment-Based and De Novo Design
Current Topics in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. :